GLP-1 RA Use Linked to Reduced Cirrhosis Risk in MASLD, Diabetes
Compared with DPP-4i use, GLP-1 RA use also associated with lower risk for composite of cirrhosis complications, mortality
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.